Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum–Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial

Goshi Nishimura   ¹ , MD, PhD ;   Hiromitsu Hatakeyama   ² , MD, PhD ;   Osamu Shiono   ³ , MD, PhD ;   Masataka Taguri   ⁴ , PhD ;   Masanori Komatsu   ² , MD, PhD ;   Daisuke Sano   ¹ , MD, PhD ;   Naoko Sakuma   ² , MD, PhD ;   Kenichiro Yabuki   ¹ , MD, PhD ;   Yasuhiro Arai   ¹ , MD ;   Kunihiko Shibata   ² , MD, ;   Yoshihiro Chiba   ¹ , MD ;   Teruhiko Tanabe   ¹ , MD ;   Nobuhiko Oridate   ¹ , MD, PhD

¹ Department of Otorhinolaryngology, Head and Neck Surgery, School of Medicine, Yokohama City University, Yokohama, Japan

² Department of Otorhinolaryngology, Yokohama City University Medical Center, Yokohama, Japan

³ Department of Otorhinolaryngology, Yokohama Rosai Hospital, Yokohama, Japan

⁴ Department of Data Science, School of Data Science, Yokohama City University, Yokohama, Japan